annual CFO:
$595.40M+$205.50M(+52.71%)Summary
- As of today (May 29, 2025), NBIX annual cash flow from operations is $595.40 million, with the most recent change of +$205.50 million (+52.71%) on December 31, 2024.
- During the last 3 years, NBIX annual CFO has risen by +$338.90 million (+132.12%).
- NBIX annual CFO is now at all-time high.
Performance
NBIX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$64.80M-$177.70M(-73.28%)Summary
- As of today (May 29, 2025), NBIX quarterly cash flow from operations is $64.80 million, with the most recent change of -$177.70 million (-73.28%) on March 31, 2025.
- Over the past year, NBIX quarterly CFO has dropped by -$65.50 million (-50.27%).
- NBIX quarterly CFO is now -73.28% below its all-time high of $242.50 million, reached on December 31, 2024.
Performance
NBIX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$529.90M-$65.50M(-11.00%)Summary
- As of today (May 29, 2025), NBIX TTM cash flow from operations is $529.90 million, with the most recent change of -$65.50 million (-11.00%) on March 31, 2025.
- Over the past year, NBIX TTM CFO has dropped by -$115.50 million (-17.90%).
- NBIX TTM CFO is now -17.90% below its all-time high of $645.40 million, reached on March 31, 2024.
Performance
NBIX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NBIX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +52.7% | -50.3% | -17.9% |
| 3 y3 years | +132.1% | +260.0% | +311.7% |
| 5 y5 years | +305.0% | +82.5% | +79.6% |
NBIX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +132.1% | -73.3% | +151.8% | -17.9% | +311.7% |
| 5 y | 5-year | at high | +305.0% | -73.3% | +151.8% | -17.9% | +311.7% |
| alltime | all time | at high | +660.7% | -73.3% | +151.8% | -17.9% | +381.5% |
NBIX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $64.80M(-73.3%) | $529.90M(-11.0%) |
| Dec 2024 | $595.40M(+52.7%) | $242.50M(+53.5%) | $595.40M(+25.0%) |
| Sep 2024 | - | $158.00M(+144.6%) | $476.40M(-10.2%) |
| Jun 2024 | - | $64.60M(-50.4%) | $530.40M(-17.8%) |
| Mar 2024 | - | $130.30M(+5.5%) | $645.40M(+65.5%) |
| Dec 2023 | $389.90M(+14.9%) | $123.50M(-41.7%) | $389.90M(-4.8%) |
| Sep 2023 | - | $212.00M(+18.0%) | $409.40M(+38.2%) |
| Jun 2023 | - | $179.60M(-243.5%) | $296.20M(+16.3%) |
| Mar 2023 | - | -$125.20M(-187.6%) | $254.70M(-25.0%) |
| Dec 2022 | $339.40M(+32.3%) | $143.00M(+44.7%) | $339.40M(+69.2%) |
| Sep 2022 | - | $98.80M(-28.5%) | $200.60M(+22.6%) |
| Jun 2022 | - | $138.10M(-441.0%) | $163.60M(+27.1%) |
| Mar 2022 | - | -$40.50M(-1064.3%) | $128.70M(-49.8%) |
| Dec 2021 | $256.50M(+12.3%) | $4.20M(-93.2%) | $256.50M(-26.0%) |
| Sep 2021 | - | $61.80M(-40.1%) | $346.80M(+31.1%) |
| Jun 2021 | - | $103.20M(+18.2%) | $264.60M(-5.6%) |
| Mar 2021 | - | $87.30M(-7.6%) | $280.30M(+22.7%) |
| Dec 2020 | $228.50M(+55.4%) | $94.50M(-563.2%) | $228.50M(-1.3%) |
| Sep 2020 | - | -$20.40M(-117.2%) | $231.50M(-33.8%) |
| Jun 2020 | - | $118.90M(+234.9%) | $349.70M(+18.5%) |
| Mar 2020 | - | $35.50M(-63.6%) | $295.00M(+100.7%) |
| Dec 2019 | $147.00M(+45.0%) | $97.50M(-0.3%) | $147.00M(+47.0%) |
| Sep 2019 | - | $97.80M(+52.3%) | $99.99M(+40.6%) |
| Jun 2019 | - | $64.20M(-157.1%) | $71.11M(+159.6%) |
| Mar 2019 | - | -$112.50M(-322.8%) | $27.39M(-73.0%) |
| Dec 2018 | $101.40M(-207.5%) | $50.49M(-26.7%) | $101.40M(+10.8%) |
| Sep 2018 | - | $68.92M(+236.5%) | $91.48M(+590.0%) |
| Jun 2018 | - | $20.48M(-153.2%) | $13.26M(-123.9%) |
| Mar 2018 | - | -$38.49M(-194.9%) | -$55.46M(-41.2%) |
| Dec 2017 | -$94.33M(-11.2%) | $40.58M(-535.8%) | -$94.33M(-43.4%) |
| Sep 2017 | - | -$9.31M(-80.7%) | -$166.53M(-11.5%) |
| Jun 2017 | - | -$48.24M(-37.6%) | -$188.23M(+22.0%) |
| Mar 2017 | - | -$77.36M(+144.6%) | -$154.33M(+45.3%) |
| Dec 2016 | -$106.18M(+179.4%) | -$31.63M(+2.0%) | -$106.18M(+18.3%) |
| Sep 2016 | - | -$31.01M(+116.3%) | -$89.76M(+16.1%) |
| Jun 2016 | - | -$14.34M(-50.9%) | -$77.32M(+57.7%) |
| Mar 2016 | - | -$29.21M(+92.1%) | -$49.02M(+29.0%) |
| Dec 2015 | -$38.00M(-19.4%) | -$15.20M(-18.1%) | -$38.00M(-0.3%) |
| Sep 2015 | - | -$18.57M(-233.0%) | -$38.10M(+20.5%) |
| Jun 2015 | - | $13.96M(-176.8%) | -$31.63M(-43.1%) |
| Mar 2015 | - | -$18.18M(+18.8%) | -$55.56M(+17.9%) |
| Dec 2014 | -$47.14M(+59.2%) | -$15.31M(+26.5%) | -$47.14M(+10.4%) |
| Sep 2014 | - | -$12.10M(+21.4%) | -$42.71M(+3.2%) |
| Jun 2014 | - | -$9.96M(+2.0%) | -$41.39M(+0.3%) |
| Mar 2014 | - | -$9.77M(-10.2%) | -$41.29M(+39.4%) |
| Dec 2013 | -$29.61M(-16.1%) | -$10.88M(+0.9%) | -$29.61M(+7.1%) |
| Sep 2013 | - | -$10.78M(+9.3%) | -$27.64M(+9.8%) |
| Jun 2013 | - | -$9.86M(-615.7%) | -$25.16M(+13.4%) |
| Mar 2013 | - | $1.91M(-121.5%) | -$22.18M(-37.2%) |
| Dec 2012 | -$35.29M(+4956.4%) | -$8.91M(+7.3%) | -$35.29M(+129.7%) |
| Sep 2012 | - | -$8.30M(+20.7%) | -$15.37M(+258.2%) |
| Jun 2012 | - | -$6.88M(-38.6%) | -$4.29M(+29.1%) |
| Mar 2012 | - | -$11.20M(-201.7%) | -$3.32M(+375.9%) |
| Dec 2011 | -$698.00K(-101.4%) | $11.02M(+297.5%) | -$698.00K(-95.7%) |
| Sep 2011 | - | $2.77M(-146.9%) | -$16.25M(-9.1%) |
| Jun 2011 | - | -$5.91M(-31.1%) | -$17.88M(-133.4%) |
| Mar 2011 | - | -$8.58M(+89.5%) | $53.55M(+7.2%) |
| Dec 2010 | $49.94M | -$4.53M(-496.8%) | $49.94M(+23.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $1.14M(-98.3%) | $40.50M(+43.3%) |
| Jun 2010 | - | $65.52M(-637.6%) | $28.26M(-155.5%) |
| Mar 2010 | - | -$12.19M(-12.8%) | -$50.89M(-4.1%) |
| Dec 2009 | -$53.09M(-28.4%) | -$13.97M(+25.9%) | -$53.09M(-4.2%) |
| Sep 2009 | - | -$11.10M(-18.6%) | -$55.41M(-6.1%) |
| Jun 2009 | - | -$13.63M(-5.3%) | -$59.01M(-2.3%) |
| Mar 2009 | - | -$14.39M(-11.7%) | -$60.39M(-18.6%) |
| Dec 2008 | -$74.17M(+25.0%) | -$16.29M(+10.9%) | -$74.17M(+19.4%) |
| Sep 2008 | - | -$14.70M(-2.1%) | -$62.10M(-9.9%) |
| Jun 2008 | - | -$15.01M(-46.7%) | -$68.91M(-5.2%) |
| Mar 2008 | - | -$28.17M(+566.5%) | -$72.65M(+22.4%) |
| Dec 2007 | -$59.33M(-40.3%) | -$4.23M(-80.3%) | -$59.33M(-17.5%) |
| Sep 2007 | - | -$21.50M(+14.6%) | -$71.91M(-14.5%) |
| Jun 2007 | - | -$18.75M(+26.3%) | -$84.15M(-10.3%) |
| Mar 2007 | - | -$14.85M(-11.6%) | -$93.84M(-5.5%) |
| Dec 2006 | -$99.33M(+222.6%) | -$16.80M(-50.2%) | -$99.33M(-5.8%) |
| Sep 2006 | - | -$33.74M(+18.6%) | -$105.44M(+304.0%) |
| Jun 2006 | - | -$28.44M(+39.8%) | -$26.10M(+3.7%) |
| Mar 2006 | - | -$20.35M(-11.2%) | -$25.16M(-18.3%) |
| Dec 2005 | -$30.79M(-69.2%) | -$22.90M(-150.2%) | -$30.79M(-16.7%) |
| Sep 2005 | - | $45.60M(-265.8%) | -$36.95M(-58.7%) |
| Jun 2005 | - | -$27.51M(+5.9%) | -$89.43M(-11.9%) |
| Mar 2005 | - | -$25.98M(-10.6%) | -$101.47M(+1.5%) |
| Dec 2004 | -$99.99M(-369.3%) | -$29.06M(+322.0%) | -$99.99M(+37.8%) |
| Sep 2004 | - | -$6.88M(-82.6%) | -$72.57M(+0.7%) |
| Jun 2004 | - | -$39.55M(+61.5%) | -$72.06M(+43.6%) |
| Mar 2004 | - | -$24.49M(+1391.6%) | -$50.18M(-235.2%) |
| Dec 2003 | $37.13M(-146.8%) | -$1.64M(-74.2%) | $37.13M(+520.6%) |
| Sep 2003 | - | -$6.38M(-63.9%) | $5.98M(-354.9%) |
| Jun 2003 | - | -$17.67M(-128.1%) | -$2.35M(-47.3%) |
| Mar 2003 | - | $62.82M(-291.6%) | -$4.45M(-94.4%) |
| Dec 2002 | -$79.36M(+263.1%) | -$32.79M(+123.0%) | -$79.36M(+70.7%) |
| Sep 2002 | - | -$14.71M(-25.7%) | -$46.49M(+40.5%) |
| Jun 2002 | - | -$19.78M(+63.6%) | -$33.09M(+28.6%) |
| Mar 2002 | - | -$12.09M(<-9900.0%) | -$25.73M(+17.7%) |
| Dec 2001 | -$21.86M(+17.2%) | $91.00K(-107.0%) | -$21.86M(-21.3%) |
| Sep 2001 | - | -$1.30M(-89.5%) | -$27.77M(-2.6%) |
| Jun 2001 | - | -$12.43M(+51.2%) | -$28.52M(+14.6%) |
| Mar 2001 | - | -$8.22M(+41.2%) | -$24.90M(+33.5%) |
| Dec 2000 | -$18.64M(+81.0%) | -$5.82M(+183.3%) | -$18.64M(+73.9%) |
| Sep 2000 | - | -$2.06M(-76.7%) | -$10.72M(-14.0%) |
| Jun 2000 | - | -$8.80M(+348.0%) | -$12.47M(+50.9%) |
| Mar 2000 | - | -$1.97M(-193.6%) | -$8.27M(-19.8%) |
| Dec 1999 | -$10.30M(-3.7%) | $2.10M(-155.3%) | -$10.30M(-31.8%) |
| Sep 1999 | - | -$3.80M(-17.4%) | -$15.10M(+31.3%) |
| Jun 1999 | - | -$4.60M(+15.0%) | -$11.50M(+27.8%) |
| Mar 1999 | - | -$4.00M(+48.1%) | -$9.00M(-15.9%) |
| Dec 1998 | -$10.70M(-197.3%) | -$2.70M(+1250.0%) | -$10.70M(-813.3%) |
| Sep 1998 | - | -$200.00K(-90.5%) | $1.50M(-78.6%) |
| Jun 1998 | - | -$2.10M(-63.2%) | $7.00M(+133.3%) |
| Mar 1998 | - | -$5.70M(-160.0%) | $3.00M(-72.7%) |
| Dec 1997 | $11.00M(+64.2%) | $9.50M(+79.2%) | $11.00M(-4.3%) |
| Sep 1997 | - | $5.30M(-186.9%) | $11.50M(+105.4%) |
| Jun 1997 | - | -$6.10M(-365.2%) | $5.60M(-51.7%) |
| Mar 1997 | - | $2.30M(-77.0%) | $11.60M(+73.1%) |
| Dec 1996 | $6.70M | $10.00M(-1766.7%) | $6.70M(-303.0%) |
| Sep 1996 | - | -$600.00K(+500.0%) | -$3.30M(+22.2%) |
| Jun 1996 | - | -$100.00K(-96.2%) | -$2.70M(+3.8%) |
| Mar 1996 | - | -$2.60M | -$2.60M |
FAQ
- What is Neurocrine Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual CFO year-on-year change?
- What is Neurocrine Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly CFO year-on-year change?
- What is Neurocrine Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM CFO year-on-year change?
What is Neurocrine Biosciences annual cash flow from operations?
The current annual CFO of NBIX is $595.40M
What is the all time high annual CFO for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual cash flow from operations is $595.40M
What is Neurocrine Biosciences annual CFO year-on-year change?
Over the past year, NBIX annual cash flow from operations has changed by +$205.50M (+52.71%)
What is Neurocrine Biosciences quarterly cash flow from operations?
The current quarterly CFO of NBIX is $64.80M
What is the all time high quarterly CFO for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly cash flow from operations is $242.50M
What is Neurocrine Biosciences quarterly CFO year-on-year change?
Over the past year, NBIX quarterly cash flow from operations has changed by -$65.50M (-50.27%)
What is Neurocrine Biosciences TTM cash flow from operations?
The current TTM CFO of NBIX is $529.90M
What is the all time high TTM CFO for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM cash flow from operations is $645.40M
What is Neurocrine Biosciences TTM CFO year-on-year change?
Over the past year, NBIX TTM cash flow from operations has changed by -$115.50M (-17.90%)